This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 12496 results found since Jan 2013.

Are DEA-waivered buprenorphine prescribers colocated with behavioral health clinicians?
CONCLUSIONS: Optimally distributing the workforce providing MOUD is necessary to broadly ensure the provision of comprehensive MOUD care based on practice guidelines.SCIENTIFIC SIGNIFICANCE: Less than half of all waivered prescribers, outside of hospitals, are colocated with behavioral health clinicians. Findings offer greater clarity on where integrated MOUD is occurring, among which types of providers, and where it needs to be expanded to increase MOUD uptake.PMID:37559344 | DOI:10.1111/ajad.13462
Source: The American Journal on Addictions - August 10, 2023 Category: Addiction Authors: Lisa de Saxe Zerden Connor Sullivan Evan Galloway Erica L Richman Maria G Gaiser Brianna Lombardi Source Type: research

California Battles Fentanyl With a New Tactic: Treating Addiction in Prison
In response to soaring overdose deaths in state prisons, California started a sprawling addiction program. But keeping people on medication during and after a sentence can be difficult.
Source: NYT - August 9, 2023 Category: American Health Authors: Noah Weiland and Rachel Bujalski Tags: Opioids and Opiates Prisons and Prisoners Buprenorphine (Drug) Drug Abuse and Traffic Fentanyl Ex-Convicts California United States Politics and Government vis-photo Source Type: news

Out-of-Pocket Costs May Serve as Barrier to Buprenorphine, Studies Suggest
Treating people with opioid use disorder (OUD) with buprenorphine is known to reduce opioid use, drug overdoses, and hospital visits, but the medication is underused. Two reports published yesterday —one appearing inJAMA Internal Medicine and another inJAMA Pediatrics—suggest that out-of-pocket costs for buprenorphine may be partly to blame for keeping the drug out of reach for adults and youth with OUD who have private health insurance.As described inJAMA Internal Medicine, Ashley A. Leech, Ph.D., M.S., of Vanderbilt University School of Medicine and colleagues used the MarketScan Commercial Claims Database to track p...
Source: Psychiatr News - August 8, 2023 Category: Psychiatry Tags: adults buprenorphine CDC JAMA Internal Medicine JAMA Pediatrics Medicaid opioid use disorder OUD out-of-pocket costs private insurance youth Source Type: research

Just 1 in 5 Americans Struggling With Opioid Misuse Gets Meds That Can Help
MONDAY, Aug. 7, 2023 -- The U.S. opioid abuse epidemic wages on, and overdose deaths continue to rise, yet just 1 in 5 people receives potentially lifesaving medication such as methadone, buprenorphine or naltrexone to treat their addiction, a new...
Source: Drugs.com - Daily MedNews - August 7, 2023 Category: General Medicine Source Type: news

Buprenorphine Cost a Potential Barrier for Opioid-Addicted Youth, Adults
(MedPage Today) -- For young people with opioid use disorder (OUD), buprenorphine costs have declined overall but with drastic variation by payer type, researchers found. Examining buprenorphine prescriptions dispensed for U.S. youth ages 12 to...
Source: MedPage Today Pediatrics - August 7, 2023 Category: Pediatrics Source Type: news

Policy in clinical practice: Elimination of the buprenorphine “X‐waiver”
Source: Journal of Hospital Medicine - August 7, 2023 Category: Hospital Management Authors: Lawrence A. Haber, Oanh K. Nguyen, Julie Taub, Marlene Martin Tags: CHOOSING WISELY ®: NEXT STEPS IN IMPROVING HEALTHCARE VALUE Source Type: research

A mobile addiction service for community-based overdose prevention - Pepin MD, Joseph JK, Chapman BP, McAuliffe C, O'Donnell LK, Marano RL, Carreiro SP, Garcia EJ, Silk H, Babu KM.
Mainstays of opioid overdose prevention include medications for opioid use disorder (e.g., methadone or buprenorphine) and naloxone distribution. Inadequate access to buprenorphine limits its uptake, especially in communities of color, and people with opio...
Source: SafetyLit - August 7, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Policy in clinical practice: Elimination of the buprenorphine “X‐waiver”
Source: Journal of Hospital Medicine - August 7, 2023 Category: Hospital Management Authors: Lawrence A. Haber, Oanh K. Nguyen, Julie Taub, Marlene Martin Tags: CHOOSING WISELY ®: NEXT STEPS IN IMPROVING HEALTHCARE VALUE Source Type: research

BUPRENORPHINE AND NALOXONE (buprenorphine hydrochloride and naloxone hydrochloride) tablet PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma
Updated Date: Mon, 07 Aug 2023 00:00:00 EDT
Source: DailyMed Drug Label Updates - August 7, 2023 Category: Drugs & Pharmacology Source Type: alerts